GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $187,125,000 | +160.9% | 862,727 | +38.8% | 3.32% | +111.6% |
| Q4 2020 | $71,711,000 | +96.3% | 621,361 | +65.5% | 1.57% | +35.5% |
| Q3 2020 | $36,540,000 | -38.0% | 375,344 | -21.8% | 1.16% | -44.5% |
| Q2 2020 | $58,923,000 | +45.6% | 480,145 | +3.9% | 2.09% | +11.3% |
| Q1 2020 | $40,479,000 | -18.0% | 462,247 | -2.1% | 1.88% | +9.3% |
| Q4 2019 | $49,392,000 | -17.8% | 472,378 | -9.6% | 1.72% | -20.6% |
| Q3 2019 | $60,094,000 | -39.5% | 522,419 | -9.3% | 2.16% | -31.6% |
| Q2 2019 | $99,346,000 | +447.4% | 576,287 | +202.7% | 3.16% | +270.4% |
| Q4 2018 | $18,150,000 | -0.8% | 190,396 | +10.1% | 0.85% | -23.0% |
| Q1 2018 | $18,302,000 | +466.1% | 172,891 | +617.0% | 1.11% | +376.0% |
| Q4 2017 | $3,233,000 | – | 24,112 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |